Chong Kun Dang Holdings Corp.

KSE 001630.KS

Chong Kun Dang Holdings Corp. EBITDA Margin for the year ending December 31, 2023: 7.08%

Chong Kun Dang Holdings Corp. EBITDA Margin is 7.08% for the year ending December 31, 2023, a 372.73% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Chong Kun Dang Holdings Corp. EBITDA Margin for the year ending December 31, 2022 was 1.50%, a -80.23% change year over year.
  • Chong Kun Dang Holdings Corp. EBITDA Margin for the year ending December 31, 2021 was 7.58%, a -45.56% change year over year.
  • Chong Kun Dang Holdings Corp. EBITDA Margin for the year ending December 31, 2020 was 13.91%, a -11.78% change year over year.
  • Chong Kun Dang Holdings Corp. EBITDA Margin for the year ending December 31, 2019 was 15.77%, a 7.64% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
SV Wall Street
KSE: 001630.KS

Chong Kun Dang Holdings Corp.

CEO Tae Young Kim
IPO Date Jan. 4, 2000
Location South Korea
Headquarters 8, Chungjeong-ro
Employees 37
Sector Healthcare
Industries
Pharmaceuticals Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Soft Drinks & Sodas
Description

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.

StockViz Staff

February 4, 2025

Any question? Send us an email